Granule proteases, which represent the major protein constituents of mast cells, have been used to identify distinct phenotypic populations in tissues. However, little is known about their functions, how they are activated, or how they are metabolized inside and outside of the mast cell. As a result of cytokine/factor-dependent regulation, mouse mast cells express varied combinations of at least seven serine proteases [designated mouse mast cell protease (mMCP) 1 to 7] and an exopeptidase [designated mouse mast cell carboxypeptidase A (mMC-CPA)] that are enzymatically active at neutral pH. Presumably, the number and type of proteases each mouse mast cell expresses are related to the number and type of proteins these effector cells must degrade or activate in their different tissue environments. Although many of the mMCPs are highly homologous with one another, each protease has its own unique set of amino acids in its substrate-binding cleft. While discrete functions seem likely, the specific substrates of each mast cell protease within and across superfamilies remain to be elucidated. The cloning of the cDNAs and genes that encode these mouse mast cell granule proteases now allows the use of two complementary approaches in this Project to address the metabolism and function of the mast cell's secretory granule proteases.
In Specific Aim 1, the chromosome 14 complex where the mast cell chymase (mMCP-1 to mMCP-5) genes reside will be mapped. Transgenic mice will be generated that have the mMC-CPA, mMCP-7, mMCP-2, and possibly other chymase genes disrupted. The consequences of ablating such genes on the development of mast cells in the transgenic animals will be assessed by morphometric and immunohistochemical analyses. Functional effects will be assessed by determining whether or not mast cell activation in a particular protease-null, transgenic animal primes the airways for augmented response to a specific agonist as does a wild type animal.
In Specific Aim 2, """"""""pro"""""""" and """"""""mature"""""""" mouse mast cell proteases will be expressed in insect cells and rat basophilic leukemia cells. These recombinant proteases will be purified and then used to assess how mast cell proteases are enzymatically activated in the granule, to examine their substrate specificities in vitro, and to determine the mechanisms by which they are metabolized in vitro and in vivo.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL036110-10
Application #
3758507
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Liu, Tao; Barrett, Nora A; Kanaoka, Yoshihide et al. (2018) Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. J Immunol 200:915-927
Liu, Tao; Garofalo, Denise; Feng, Chunli et al. (2015) Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors. J Immunol 194:5061-8
Laidlaw, Tanya M; Cutler, Anya J; Kidder, Molly S et al. (2014) Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 133:1692-701.e3
Fanning, Laura B; Buckley, Carolyn C; Xing, Wei et al. (2013) Downregulation of key early events in the mobilization of antigen-bearing dendritic cells by leukocyte immunoglobulin-like Receptor B4 in a mouse model of allergic pulmonary inflammation. PLoS One 8:e57007
Ohta, Shin; Imamura, Mitsuru; Xing, Wei et al. (2013) Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. J Immunol 190:5927-38
Cummings, Hannah E; Liu, Tao; Feng, Chunli et al. (2013) Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. J Immunol 191:5807-10
Liu, Tao; Laidlaw, Tanya M; Katz, Howard R et al. (2013) Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A 110:16987-92
Laidlaw, Tanya M; Kidder, Molly S; Bhattacharyya, Neil et al. (2012) Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 119:3790-8
Simarro, Maria; Giannattasio, Giorgio; Xing, Wei et al. (2012) The translational repressor T-cell intracellular antigen-1 (TIA-1) is a key modulator of Th2 and Th17 responses driving pulmonary inflammation induced by exposure to house dust mite. Immunol Lett 146:8-14
Lundequist, Anders; Boyce, Joshua A (2011) LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1? release. PLoS One 6:e18192

Showing the most recent 10 out of 200 publications